EVGN - Evogene Ltd.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
2.1510
-0.0490 (-2.23%)
At close: 11:43AM EST
Stock chart is not supported by your current browser
Previous Close2.2000
Open2.2000
Bid2.120 x 3000
Ask3.590 x 900
Day's Range2.1501 - 2.2000
52 Week Range2.1500 - 4.2000
Volume1,229
Avg. Volume3,444
Market Cap57.192M
Beta (3Y Monthly)0.75
PE Ratio (TTM)N/A
EPS (TTM)-0.822
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
Trade prices are not sourced from all markets
  • GlobeNewswire18 days ago

    Evogene’s Leading Insect Control Genes Demonstrate Effectiveness Against Insects with Resistance to Current Commercial Solutions

    Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announces today that a well-recognized external laboratory and in-house testing had confirmed that leading Evogene insect control genes demonstrated efficacy against insects with resistance to current commercial insect control products, including fall armyworm and diamondback moth.

  • GlobeNewswire26 days ago

    AgPlenus, a subsidiary of Evogene, to Present at the 2nd Annual AgChem & Technology Europe Conference

    REHOVOT, Israel, Nov. 19, 2018 -- AgPlenus, a fully owned subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), an innovative company aiming to discover, develop and bring to the.

  • GlobeNewswire26 days ago

    Evogene Announces Establishment of Ag-Chemicals Subsidiary – AgPlenus Ltd.

    REHOVOT, Israel, Nov. 19, 2018 (GLOBE NEWSWIRE) --  Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today the establishment of a new subsidiary – AgPlenus Ltd.  All of Evogene’s ag-chemical activities focusing on the design and development of effective and safe next generation agro-chemical products are being transferred to the new subsidiary, along with access to Evogene’s Computational Predictive Biology (“CPB”) platform. The ag-chemical activities being transferred to AgPlenus, which were initiated in 2014, now consist of a substantial internal and collaborative product pipeline focusing on herbicides and insecticides with a clear go-to-market strategy.

  • Associated Presslast month

    Evogene: 3Q Earnings Snapshot

    On a per-share basis, the Rehovot, Israel-based company said it had a loss of 19 cents. The agricultural company posted revenue of $367,000 in the period. The company's shares closed at $2.73. A year ago, ...

  • GlobeNewswirelast month

    Evogene Reports Third Quarter 2018 Financial Results

    REHOVOT, Israel, Nov. 14, 2018 -- Conference call and webcast, today at 9:00 am Eastern Time Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing.

  • GlobeNewswirelast month

    Biomica Announces the Addition of Internationally Renowned Experts in the Fields of Gastroenterology and the Human Microbiome to its Scientific Advisory Board

    REHOVOT, Israel, Nov. 06, 2018 (GLOBE NEWSWIRE) --  Biomica, a subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), an emerging biopharmaceutical company developing innovative microbiome-based therapeutics announced today that internationally renowned experts have joined the company’s scientific advisory board. The experts will join Prof. Yehuda Ringel, Biomica co-founder and CSO, an internationally recognized thought leader in the field of the functional gastrointestinal disorders and the intestinal microbiome, in order to support the company’s upcoming steps towards its clinical development. Prof. Willem M De Vos is Professor and Chair of Microbiology at Wageningen University, the Netherlands and Professor of Human Microbiomics at the University of Helsinki, Finland, where he also served as Finland Distinguished and Academy Professor.

  • GlobeNewswire2 months ago

    Evofuel and Fantini s.r.l Announce Breakthrough in Mechanical Harvesting for Castor Bean

    Evofuel Ltd., a wholly owned subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), focused on securing the global demand for stable castor oil supply and Fantini s.r.l., a leading manufacturer and distributor of agricultural equipment, announced today the successful development of a mechanical harvesting solution for castor bean plants.  The solution developed has shown a significant decrease in yield losses, from up to 50% with the current solutions to as low as 5% with the combination of the harvester and Evofuel proprietary castor varieties and growth protocols in two consecutive year field trials in Israel during 2017-2018. The global castor oil and derivatives market is expected to reach USD 2.3 billion by 20241.

  • GlobeNewswire2 months ago

    Evogene Financial Results for the Third Quarter of 2018 Earnings Announcement Schedule

    REHOVOT, Israel, Oct. 24, 2018 -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it.

  • Associated Press4 months ago

    Evogene: 2Q Earnings Snapshot

    On a per-share basis, the Rehovot, Israel-based company said it had a loss of 19 cents. The agricultural company posted revenue of $379,000 in the period. The company's shares closed at $2.88. A year ago, ...

  • ACCESSWIRE4 months ago

    Evogene Ltd to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Evogene Ltd (NASDAQ: EVGN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 9:00 AM Eastern Time. To listen ...

  • ACCESSWIRE7 months ago

    Blog Exposure - Evogene Signs Collaboration Agreement with BASF for Development of Novel Insecticides

    LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free research report on Evogene Ltd (NASDAQ: EVGN), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=EVGN as the Company's latest news hit the wire. On May 29, 2018, the Company, which is a leading biotechnology organization developing novel products for life science markets, and BASF, which is one of the world's leading chemical Companies, declared on May 29, 2018, that they have signed a new collaboration agreement for the development of novel insecticides based on new binding areas (Site-of-Action or ‘SoA') on key insecticidal target proteins. Active-Investors.com is currently working on the research report for Oncobiologics, Inc. (NASDAQ: ONS), which also belongs to the Healthcare sector as the Company Evogene.

  • Associated Press7 months ago

    Evogene: 1Q Earnings Snapshot

    On a per-share basis, the Rehovot, Israel-based company said it had a loss of 21 cents. The agricultural company posted revenue of $366,000 in the period. The company's shares closed at $3.10. A year ago, ...

  • Associated Press10 months ago

    Evogene reports 4Q loss

    The Rehovot, Israel-based company said it had a loss of 24 cents per share. The agricultural company posted revenue of $734,000 in the period. For the year, the company reported that its loss widened to ...